You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 6, 2025

Details for Patent: 8,435,502


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,435,502 protect, and when does it expire?

Patent 8,435,502 protects DIFFERIN and is included in one NDA.

This patent has seventeen patent family members in twelve countries.

Summary for Patent: 8,435,502
Title:Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers
Abstract: Cosmetic/dermatological compositions for topical application and useful for the treatment, e.g., of acne, contain, formulated into a physiologically acceptable medium, at least one naphthoic acid compound and at least one polyurethane polymer or derivative thereof, the at least one naphthoic acid compound being dispersed therein.
Inventor(s): Mallard; Claire (Mougins, FR), Ferrara; Eve (Valbonne, FR)
Assignee: Galderma Research & Development (Biot, FR)
Application Number:13/171,872
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,435,502

Introduction

United States Patent 8,435,502, titled "Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers," is a patent that covers specific formulations and methods for treating dermatological conditions. Here, we will delve into the details of the patent's scope, claims, and the broader patent landscape in which it resides.

Patent Overview

The patent, assigned to a company involved in cosmetic and dermatological research, describes compositions and methods for the treatment of skin conditions such as acne. These compositions include naphtholic acid compounds and polyurethane polymers, which are formulated for topical application[2].

Claims

The patent includes several claims that define the scope of the invention. Here are some key claims:

Independent Claims

  • Claim 1 typically describes the broadest aspect of the invention, which in this case might include the composition comprising naphtholic acid compounds and polyurethane polymers.
  • Claim 2 and subsequent claims may narrow down the invention by specifying particular concentrations of the compounds, methods of application, or specific dermatological conditions treated.

Dependent Claims

  • These claims build upon the independent claims, adding additional limitations or specifications. For example, a dependent claim might specify a particular ratio of naphtholic acid to polyurethane polymer or a specific method of preparation.

Scope of the Invention

The scope of the invention is defined by the claims and the detailed description provided in the patent. Here are some key aspects:

Active Ingredients

  • The patent focuses on the use of naphtholic acid compounds, which are known for their dermatological benefits, particularly in treating acne.
  • Polyurethane polymers are included to enhance the stability and delivery of the active ingredients.

Formulation

  • The compositions are formulated for topical application, indicating that they are designed to be applied directly to the skin.
  • The patent may specify various forms of the composition, such as creams, gels, or ointments.

Methods of Treatment

  • The patent describes methods for treating dermatological conditions, including acne, using the specified compositions.

Patent Landscape Analysis

Saturated Patent Space

The field of dermatological and cosmetic compositions is highly saturated with patents. Conducting a patent landscape analysis is crucial to understand the competitive landscape and potential barriers to entry. This analysis helps in identifying existing patents, pending applications, and the overall saturation level in the technology area[3].

Competitors and Related Patents

  • A comprehensive patent landscape analysis would reveal other patents and applications related to dermatological treatments, including those from competitors.
  • This analysis can help in identifying gaps in the current technology and potential areas for innovation.

Global Patent System

  • The patent landscape extends beyond the U.S., involving international patent offices. Tools like the Global Dossier and Common Citation Document (CCD) can provide insights into related applications and citations across different jurisdictions[4].

Allowance Rates and Patent Prosecution

The probability of receiving a U.S. patent, as studied by Carley, Hegde, and Marco, indicates that only about 55.8% of patent applications are eventually granted without using continuation procedures. This rate varies significantly across different technology fields, with "Drugs and Medical Instruments" and "Computers and Communications" fields showing a decrease in allowance rates over time[1].

Implications for Inventors and Policymakers

  • For inventors, understanding the patent landscape and the specific claims of existing patents like US 8,435,502 is crucial for avoiding infringement and identifying novel aspects of their inventions.
  • Policymakers can use data from patent landscape analyses to inform policies related to intellectual property, innovation, and competition in the pharmaceutical and cosmetic industries.

Tools for Patent Searching

Several tools are available for conducting thorough patent searches, including the USPTO's Patent Public Search, Global Dossier, and resources from international intellectual property offices. These tools help in identifying prior art, tracking the status of related applications, and analyzing the patent family of a specific application[4].

Conclusion

Understanding the scope and claims of United States Patent 8,435,502 requires a detailed analysis of the patent document itself, as well as a broader examination of the patent landscape. This involves identifying key claims, understanding the formulation and methods described, and analyzing the competitive and regulatory environment in which the patent exists.

Key Takeaways

  • Patent Claims: The patent includes specific claims defining the composition and method of treatment using naphtholic acid compounds and polyurethane polymers.
  • Patent Landscape: The field is highly saturated, requiring a comprehensive analysis to identify competitors, related patents, and potential gaps in technology.
  • Global Implications: The patent's validity and enforcement extend beyond the U.S., involving international patent offices and regulations.
  • Tools for Analysis: Utilize tools like the USPTO's Patent Public Search and Global Dossier to conduct thorough patent searches and analyses.

FAQs

Q: What are the main components of the compositions described in US 8,435,502? A: The compositions include naphtholic acid compounds and polyurethane polymers.

Q: What is the primary use of the compositions described in the patent? A: The compositions are primarily used for the treatment of dermatological conditions such as acne.

Q: How can one conduct a thorough patent search related to this patent? A: Use tools like the USPTO's Patent Public Search, Global Dossier, and resources from international intellectual property offices.

Q: What is the significance of patent landscape analysis in this context? A: It helps in understanding the competitive landscape, identifying potential barriers to entry, and finding gaps in current technology.

Q: What is the general allowance rate for patent applications in the U.S.? A: Approximately 55.8% of patent applications are eventually granted without using continuation procedures[1].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203-215.
  2. US8435502B2 - Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers. Google Patents.
  3. Patent Landscape Analysis - Uncovering Strategic Insights. AcclaimIP.
  4. Search for patents - USPTO. United States Patent and Trademark Office.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,435,502

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Galderma Labs Lp DIFFERIN adapalene LOTION;TOPICAL 022502-001 Mar 17, 2010 DISCN Yes No 8,435,502 ⤷  Subscribe Y TREATMENT OF ACNE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,435,502

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France05 09493Sep 16, 2005

International Family Members for US Patent 8,435,502

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 057866 ⤷  Subscribe
Australia 2006290364 ⤷  Subscribe
Brazil PI0617045 ⤷  Subscribe
Canada 2622468 ⤷  Subscribe
China 101262862 ⤷  Subscribe
China 104013540 ⤷  Subscribe
European Patent Office 1933827 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.